Kevin J Curran

4PUBLICATIONS
26CO-AUTHORS
HaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 01, 2023
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.

Kevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa

|Sep 15, 2022
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.

Liora M Schultz, Anne Eaton, Christina Baggott

|Nov 17, 2021
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy.

Vanessa A Fabrizio, Jaap Jan Boelens, Audrey Mauguen

|Oct 26, 2019
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.

Kevin J Curran, Steven P Margossian, Nancy A Kernan

Pageof 1

Frequent Collaborators

3 joint publications

Snehit Prabhu

3 joint publications

Jenna Rossoff

3 joint publications

Michael Verneris

3 joint publications

Crystal L Mackall